Michael Dean
20Patents
3h-index
63Co-inventors
62Inventor score
Filing activity: May 16, 1997 → Aug 10, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6713300B1 | Nucleic acid and amino acid sequences for ATP-binding cassette transporter and methods of screening for agents that modify ATP-binding cassette transporter | Human Necessities | 13 | Expired |
| US6552181B1 | Basal cell carcinoma tumor supressor gene | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7138493B1 | ATP-binding cassette protein responsible for cytotoxin resistance | Chemistry; Metallurgy | 3 | Expired |
| US9063139B2 | Variants in complement regulatory genes predict age-related macular degeneration | Physics | 3 | Active |
| US6600030B2 | Delayed progression to aids by a missense allele of the CCR2 gene | Chemistry; Metallurgy | 2 | Expired |
| US7192579B2 | Methods of gene therapy using nucleic acid sequences for ATP-binding cassette transporter | Human Necessities | 2 | Expired |
| US6867017B1 | ATP-binding transporter (ABC7) and methods for detection of anemia and ataxia | Physics | 2 | Expired |
| US7317086B2 | Basal cell carcinoma tumor suppressor protein | Emerging Cross-Sectional Technologies | 1 | Expired |
| US8012683B2 | Variants in complement regulatory genes predict age-related macular degeneration | Physics | 1 | Active |
| US7141420B2 | Nucleic acid and amino acid sequences for ATP-binding cassette transporter and methods of screening for agents that modify ATP-binding cassette transporter | Human Necessities | 1 | Expired |
| US8470888B2 | Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer | Chemistry; Metallurgy | 0 | Active |
| US8546524B2 | Smoothened polypeptides and methods of use | Human Necessities | 0 | Active |
| US9114102B2 | Method of inhibiting ABCG2 and related treatments | Human Necessities | 0 | Active |
| US8198402B2 | Smoothened polypeptides and methods of use | Human Necessities | 0 | Active |
| US9937217B2 | Method of inhibiting ABCG2 and related treatments | Human Necessities | 0 | Active |
| US6893841B2 | Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof | Chemistry; Metallurgy | 0 | Expired |
| US9314448B2 | Method of inhibiting ABCG2 and other treatment methods | Chemistry; Metallurgy | 0 | Active |
| US8129353B2 | Methods of gene therapy using nucleic acid sequences for ATP-binding cassette transporter | Human Necessities | 0 | Active |
| US7189511B2 | Methods of screening and diagnostics using ATP-binding cassette transporter | Human Necessities | 0 | Expired |
| US9328142B2 | Lipopeptide inhibitors of RAS oncoproteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.